文献速递消化系统肿瘤

幽门螺杆菌根除治疗后胰腺癌风险变化

Risk of pancreatic cancer after eradication treatment of Helicobacter pylori.
PubMed 文献 · Eur J Cancer · 2025-12-18

这项多国基于人群的队列研究纳入丹麦、芬兰、冰岛、挪威和瑞典1995至2019年接受幽门螺杆菌根除治疗的成人,随访至24年。根除治疗后1-5年胰腺癌风险升高(SIR 1.14,95%CI 1.07-1.21),6-10年(SIR 0.99,95%CI 0.92-1.07)和11-24年(SIR 1.00,95%CI 0.92-1.08)降至背景人群水平。提示根除治疗可能使幽门螺杆菌感染相关胰腺癌风险随时间下降。

要点

  • 根除治疗后1-5年胰腺癌风险轻度升高(SIR 1.14)。
  • 6-10年及11-24年风险与背景人群相当。
  • 幽门螺杆菌感染相关胰腺癌风险随根除后时间下降。

核心结论

  • 幽门螺杆菌感染者根除治疗后胰腺癌风险随时间下降,最终达到背景人群水平。

研究设计与样本

  • 多国基于人群的队列研究,使用1995至2019年前瞻性收集的全国登记数据。
  • 纳入丹麦、芬兰、冰岛、挪威和瑞典所有接受幽门螺杆菌根除治疗的成人,共661,827人,5494,255人年。

主要发现

  • 随访至24年,2331名参与者发生胰腺癌。
  • 根除治疗后1-5年胰腺癌风险升高(SIR 1.14,95%CI 1.07-1.21)。
  • 6-10年风险与背景人群相似(SIR 0.99,95%CI 0.92-1.07)。
  • 11-24年风险与背景人群相似(SIR 1.00,95%CI 0.92-1.08)。

临床怎么用

  • 对幽门螺杆菌感染者行根除治疗可能降低其后续胰腺癌风险。
  • 根除治疗后早期(1-5年)仍需关注胰腺癌风险轻度升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Helicobacter pylori infection seems to increase the risk of developing pancreatic cancer, but it is unknown whether eradication treatment of this bacterium changes this risk. We hypothesized that the increased risk of pancreatic cancer among individuals infected with Helicobacter pylori decreases over time after eradication treatment. METHODS: This multinational and population-based cohort study, using prospectively collected nationwide register data from 1995 to 2019, included all adults who received eradication treatment for Helicobacter pylori in Denmark, Finland, Iceland, Norway, or Sweden. Standardized incidence ratios (SIR) with 95 % confidence intervals (95 %CI) were calculated by dividing the incidence rates of pancreatic cancer in the eradication treatment cohort by that of the entire populations of the corresponding age, sex, calendar year, and country. The main outcome was changes in SIR over time after eradication treatment. RESULTS: During up to 24 years of follow-up of 661,827 participants and 5494,255 person-years in the eradication treatment cohort, 2331 participants developed pancreatic cancer. The risk of pancreatic cancer was increased during the first 1-5 years after eradication treatment (SIR 1.14, 95 % CI 1.07-1.21), after which it decreased and became similar to the level of the background population 6-10 years (SIR 0.99, 95 % CI 0.92-1.07) and 11-24 years (SIR 1.00, 95 % CI 0.92-1.08) after eradication treatment. CONCLUSION: The elevated risk of developing pancreatic cancer among individuals with Helicobacter pylori infection seems to decrease after eradication treatment, reaching the risk estimates of the background population.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Wiklund AK, Santoni G, Radkiewicz C, et al. Risk of pancreatic cancer after eradication treatment of Helicobacter pylori. Eur J Cancer. 2025. PMID: 41421173. doi:10.1016/j.ejca.2025.116192

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。